Zobrazeno 1 - 5
of 5
pro vyhledávání: '"María Merino Salvador"'
Autor:
María Merino Salvador, Lara Paula Fernández, Juan Moreno-Rubio, Gonzalo Colmenarejo, Enrique Casado, Ana Ramírez de Molina, María Sereno
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Lung cancer is one of the most lethal tumors with a poor survival rate even in those patients receiving new therapies. Metabolism is considered one of the hallmarks in carcinogenesis and lipid metabolism is emerging as a significa
Externí odkaz:
https://doaj.org/article/930f2f39789741ce96e897d9a8f3fb99
Autor:
Enrique Casado, Ruth Sánchez Martínez, Sandra Falagán Martínez, Juan Moreno Rubio, María Sereno, Ana Ramírez de Molina, Marta Gómez de Cedrón, María Merino Salvador
Publikováno v:
Critical Reviews in Oncology/Hematology. 112:31-40
Lung cancer is currently one of the most serious health issues in developed and developing countries. There are multiple available treatment options; however survival still remains very poor. Despite metabolism alteration being one of the hallmarks d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ade83de938481e6d0d135553c0a713a
https://doi.org/10.1016/j.critrevonc.2017.02.001
https://doi.org/10.1016/j.critrevonc.2017.02.001
Publikováno v:
Cancer chemotherapy and pharmacology. 85(3)
The role of adjuvant chemotherapy (CT) is controversial in endometrial carcinoma (EC). Surgery alone is usually curative for women who are at a low risk of disease recurrence. The treatment of EC following surgical staging is based on the risk of rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2e086eec69d9be524bb2159e214706
https://pubmed.ncbi.nlm.nih.gov/31950214
https://pubmed.ncbi.nlm.nih.gov/31950214
Autor:
Sandra Falagán Martínez, Marta Gómez de Cedrón, María Merino Salvador, María Sereno, Enrique Casado, Ruth Sánchez Martínez, Juan Moreno Rubio, Ana Ramírez de Molina
Publikováno v:
Critical reviews in oncology/hematology. 133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ee2814ae36b38dd41475c5e54c36098
https://pubmed.ncbi.nlm.nih.gov/28325263
https://pubmed.ncbi.nlm.nih.gov/28325263
Autor:
Jose Lorenzo Vazquez Osorio, Javier Heras, César Gómez-Raposo, Mar Carballo, Clara Garcia de Santiago, María F. Sereno-Moyano, Enrique Casado, Francisco Zambrana Tevar, Ines Suarez-Garcia, M. Isabel Esteban, Miriam López-Gómez, María Merino Salvador, Monica Andreu, Eva Pelayo
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 14(6)
Changes in magnetic resonance imaging (MRI) during neoadjuvant chemotherapy (NAC) have been reported as predictive of pathology outcome in triple-negative and HER2-positive breast cancer. The purpose of our study was to evaluate the relevance of brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbf89c527ff6846ae274ce65da94338
https://pubmed.ncbi.nlm.nih.gov/22634539
https://pubmed.ncbi.nlm.nih.gov/22634539